Thomas Hartung

1.
Sebastian Schmeisser, Andrea Miccoli, Martin von Bergen, et al. New approach methodologies in human regulatory toxicology – Not if, but how and when!. Environment International. 2023;178:108082. doi:10.1016/j.envint.2023.108082
View Full Reference
1.
Jean Knight, Thomas Hartung, Costanza Rovida. 4.2 million and counting… The animal toll for REACH systemic toxicity studies. ALTEX - Alternatives to animal experimentation. 2023;40(3):389-407. doi:10.14573/altex.2303201
View Full Reference
1.
Costanza Rovida, Francois Busquet, Marcel Leist, Thomas Hartung. REACH out-numbered! The future of REACH and animal numbers. ALTEX - Alternatives to Animal Experimentation. 2023;40(3):367-388. doi:10.14573/altex.2307121
View Full Reference
1.
Camilla Svendsen, Paul Whaley, Gunn E. Vist, et al. Protocol for designing INVITES-IN, a tool for assessing the internal validity of in vitro studies. Evidence-Based Toxicology. 2023;1(1):2232415. doi:10.1080/2833373X.2023.2232415
View Full Reference
1.
Paula Barreras, David Pamies, Thomas Hartung, Carlos A. Pardo. Human brain microphysiological systems in the study of neuroinfectious disorders. Experimental Neurology. 2023;365:114409. doi:10.1016/j.expneurol.2023.114409
View Full Reference
1.
Robert Jordan, Stephanie L Ford-Scheimer, Rodolfo M Alarcon, et al. Report of the Assay Guidance Workshop on 3-Dimensional Tissue Models for Antiviral Drug Development. The Journal of Infectious Diseases. 2023:jiad334. doi:10.1093/infdis/jiad334
View Full Reference
1.
Daniel Krewski, Patrick Saunders-Hastings, Robert A. Baan, et al. Development of an Evidence-Based Risk Assessment Framework. ALTEX. 2022;39(4):667-693. doi:10.14573/altex.2004041
View Full Reference
1.
David Pamies, Marcel Leist, Sandra Coecke, et al. Guidance document on Good Cell and Tissue Culture Practice 2.0 (GCCP 2.0). Alternatives to Animal Experimentation. 2022;39(1):30-70. doi:10.14573/altex.2111011
View Full Reference
1.
Uwe Marx, Takafumi Akabane, Tommy B. Andersson, et al. Biology-inspired microphysiological systems to advance patient benefit and animal welfare in drug development. ALTEX. 2020;37(3):365-394. doi:10.14573/altex.2001241
View Full Reference
1.
Thomas Hartung, Rob De Vries, Sebastian Hoffmann, et al. Toward Good In Vitro Reporting Standards. Alternatives to Animal Experimentation. 2019;36(1):3-17. doi:10.14573/altex.1812191
View Full Reference